SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dennis C who wrote (718)5/7/1997 7:13:00 PM
From: Rocketman   of 1172
 
It just goes to show ya, it's always somethin'!!!!

I don't think that CMTR is ever going to get respect based on speculation. I think the only thing that will count is the increasing revenue stream over time, and the only proof of that is in the quarterly financials. They may get a short lived spike when they get the HIV test approval, but I expect that it too will be short-lived and the price will fall back while the wait for revenue figures continues. CMTR's only product history is a big revenue disappointment, and that fact will haunt them until they turn it around with $, not press releases of the future to come. What I like is that with a ~$17M market cap. and a low burn rate, it will not take much revenue to make this a profitable company, and that WILL impress the markets. Keep in mind that virtually all of the CMTR products can be viewed as "me too" in some way. They do not have really unique one of a kind products. That doesn't mean they can't make money doing what they do, but it makes it hard to sell it on speculation.

Rman
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext